| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |